(S1 (S (S (NP (JJ Bee) (NN venom)) (VP (VP (VBZ induces) (NP (NN apoptosis))) (CC and) (VP (VBZ inhibits) (NP (NP (NN expression)) (PP (IN of) (NP (NN cyclooxygenase-2) (NN mRNA))) (PP (IN in) (NP (NP (JJ human) (NN lung) (NN cancer) (NN cell) (NN line)) (NP (NN NCI-H1299)))))))) (. .)))
(S1 (S (S (S (VP (TO To) (VP (VB investigate) (SBAR (IN whether) (S (NP (NP (NN bee) (NN venom)) (PRN (-LRB- -LRB-) (NP (NN BV)) (-RRB- -RRB-))) (VP (VBZ induces) (NP (NN apoptosis)))))))) (, ,) (NP (NP (DT the) (NN 3--LRB-4,5-dimethylthiazol-2-yl-RRB--2,5-diphenyltetrazolium) (NN bromide) (NN assay)) (, ,) (NP (NP (JJ terminal) (NN deoxynucleotidyl) (JJ transferase-) (JJ mediated) (NN dUTP) (NN nick) (NN end-labeling)) (NN assay)) (, ,) (NP (JJ 4,6-diamidino-2-phenylindole) (NN staining)) (, ,) (NP (NN flow) (JJ cytometric) (NN analysis)) (, ,) (CC and) (NP (NN DNA) (NN fragmentation) (NN assay))) (VP (VBD were) (VP (VBN performed) (PP (IN on) (NP (NP (NN NCI-H1299) (NN lung) (NN cancer) (NNS cells)) (VP (VBN treated) (PP (IN with) (NP (NN BV))))))))) (. .)))
(S1 (S (S (PP (IN Through) (NP (ADJP (ADJP (JJ morphological)) (CC and) (ADJP (JJ biochemical))) (NNS analyses))) (, ,) (NP (PRP it)) (VP (VBD was) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NP (NN NCI-H1299) (NNS cells)) (VP (VBN treated) (PP (IN with) (NP (NN BV))))) (VP (VBP exhibit) (NP (NP (JJ several) (NNS features)) (PP (IN of) (NP (NN apoptosis)))))))))) (. .)))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NP (JJ reverse) (NN transcription-polymerase) (NN chain) (NN reaction)) (CC and) (NP (NP (NN prostaglandin) (NN E-LRB-2-RRB-)) (PRN (-LRB- -LRB-) (NP (NN PGE-LRB-2-RRB-)) (-RRB- -RRB-)))) (NN immunoassay)) (VP (VBD were) (VP (VBN performed) (S (VP (TO to) (VP (VB verify) (SBAR (IN whether) (S (NP (NN BV)) (VP (VBZ possesses) (NP (NP (DT an) (JJ inhibitory) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NP (NP (NN cyclooxygenase)) (PRN (-LRB- -LRB-) (NP (NN COX)) (-RRB- -RRB-))) (CC and) (NP (NN PGE) (-LRB- -LRB-) (CD 2) (-RRB- -RRB-))) (NN synthesis))))))))))))))) (. .)))
(S1 (S (S (NP (NP (NP (NN Expression)) (PP (IN of) (NP (NN COX-2) (NN mRNA)))) (CC and) (NP (NP (NN synthesis)) (PP (IN of) (NP (NN PGE-LRB-2-RRB-))))) (VP (VBD were) (VP (VBN inhibited) (PP (IN by) (NP (NN BV)))))) (. .)))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP (NN BV)) (VP (MD may) (VP (VB exert) (NP (DT an) (JJ anti-tumor) (NN effect)) (PP (IN on) (NP (JJ human) (NN lung) (NN cancer)))))))))) (. .)))
